Evidence map›Paper›PMID 36273031›Full record

ArticleScientific reports2022

Hydrogel-based microfluidic device with multiplexed 3D in vitro cell culture.

Allison Clancy, Dayi Chen, Joseph Bruns, Jahnavi Nadella, Samuel Stealey, Yanjia Zhang, Aaron Timperman, Silviya P Zustiak

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Allison ClancyDepartment of Biomedical Engineering, Saint Louis University, St Louis, MO, 63103-2010, USA.
Dayi ChenDepartment of Bioengineering, and Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
Joseph BrunsDepartment of Biomedical Engineering, Saint Louis University, St Louis, MO, 63103-2010, USA.
Jahnavi NadellaDepartment of Biomedical Engineering, Saint Louis University, St Louis, MO, 63103-2010, USA.
Samuel StealeyDepartment of Biomedical Engineering, Saint Louis University, St Louis, MO, 63103-2010, USA.
Yanjia ZhangDepartment of Bioengineering, and Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
Aaron TimpermanDepartment of Bioengineering, and Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA. atimperm@seas.upenn.edu.
Silviya P ZustiakDepartment of Biomedical Engineering, Saint Louis University, St Louis, MO, 63103-2010, USA. silviya.zustiak@slu.edu.
Saint Louis University · USUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microfluidic devices that combine an extracellular matrix environment, cells, and physiologically relevant perfusion, are advantageous as cell culture platforms. We developed a hydrogel-based, microfluidic cell culture platform by loading polyethylene glycol (PEG) hydrogel-encapsulated U87 glioblastoma cells into membrane-capped wells in polydimethyl siloxane (PDMS). The multilayer microfluidic cell culture system combines previously reported design features in a configuration that loads and biomimetically perfuses a 2D array of cell culture chambers. One dimension of the array is fed by a microfluidic concentration gradient generator (MCGG) while the orthogonal dimension provides loading channels that fill rows of cell culture chambers in a separate layer. In contrast to typical tree-like MCGG mixers, a fractional serial dilution of 1, ½, ¼, and 0 of the initial solute concentration is achieved by tailoring the input microchannel widths. Hydrogels are efficiently and reproducibly loaded in all wells and cells are evenly distributed throughout the hydrogel, maintaining > 90% viability for up to 4 days. In a drug screening assay, diffusion of temozolomide and carmustine to hydrogel-encapsulated U87 cells from the perfusion solution is measured, and dose-response curves are generated, demonstrating utility as an in vitro mimic of the glioblastoma microenvironment.

Indexed as

GlioblastomaHydrogelsCarmustineCell Culture TechniquesHumansLab-On-A-Chip DevicesPolyethylene GlycolsSiloxanesTemozolomideTumor MicroenvironmentCarmustineHydrogelsPolyethylene GlycolsSiloxanesTemozolomide

Identifiers

PMID36273031
PMCPMC9588086
OpenAlexW4307139392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.